<p>Shown are for each pathologist the fraction of MIB-1-LI results over the mean value calculated for the entire group of 15 pathologists. Red and yellow circles indicate results obtained in self- selected and predefined areas, respectively. Mean values are shown in horizontal bars. The interobserver variabilities were comparable to the results obtained four months prior on the same slides (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037379#pone-0037379-g004" target="_blank"><b>figure 4B</b></a>). The data shown in the right panels (B,D) were then modified by a “correction factor” for each individual pathologist. This correction factor was calculated from the results obtained on three independent carcinomas, s...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
The assessment of PD-L1 expression in TNBC is a prerequisite for selecting patients for immunotherap...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...
<p>Mean values over the ten carcinomas are shown in horizontal bars and standard deviations in verti...
<p>The upper panels (A,C) are eyeballed and the lower panels (B,D) counted data. Despite marked vari...
<p>Shown are in each panel the MIB-1-LI results for each pathologist during step 2 of the study (lef...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
<p>The linear correlations were calculated separately for data obtained by eyeballing (upper panels,...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...
Background Postanalytic issues of Ki67 assessment in breast cancers like counting method standardisa...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Aim Pathological predictive factors are the most important markers when selecting early breast cance...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
The assessment of PD-L1 expression in TNBC is a prerequisite for selecting patients for immunotherap...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...
<p>Mean values over the ten carcinomas are shown in horizontal bars and standard deviations in verti...
<p>The upper panels (A,C) are eyeballed and the lower panels (B,D) counted data. Despite marked vari...
<p>Shown are in each panel the MIB-1-LI results for each pathologist during step 2 of the study (lef...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
<p>The linear correlations were calculated separately for data obtained by eyeballing (upper panels,...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...
Background Postanalytic issues of Ki67 assessment in breast cancers like counting method standardisa...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Aim Pathological predictive factors are the most important markers when selecting early breast cance...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
The assessment of PD-L1 expression in TNBC is a prerequisite for selecting patients for immunotherap...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...